Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis
NCT ID: NCT06630403
Last Updated: 2024-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-09-05
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Balance, Cognıtıve Skılls, Hand Functıons and Qualıty of Lıfe Among Patients with Bronchiectasis and Healthy Peers
NCT06606665
Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study
NCT02564731
Investigation of Dynamic Hyperinflation and Its Relationship With Functional Exercise Capacity in Children With Bronchiectasis
NCT04885790
Determination of Physical Fitness Level in Bronchiectasis
NCT07121218
Comparison of Sit-to-stand Test With Six-minute Walk Test in Bronchiectasis and Healthy Children
NCT04153448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with Bronchiectasis Experiment Group
Children with bronchiectasis Participants will be required to sign an informed consent form before the evaluation.
Assesment Methods:
1. Demographic data will be collected verbally.
2. The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.
3. Pulmonary Function Test will be applied.
4. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
5. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test.
6. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea.
7. Quality of life will be assessed with the "Quality of Life Scale for Children".
8. Fear of movement will be assessed with the Tampa Kinesiophobia Scale.
9. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery.
10. Cognitive functions will be assessed with Trail Making Test and Stroop Test.
Demographic Data
Demographic data (age, height, weight, BMI) will be collected verbally through an assessment form.
Disease History
The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.
Pulmonary Function Test
Pulmonary Function Test will be performed with a spirometer.
Reaction Time
Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
Functional Capacity
Functional capacity will be evaluated with 6 minute walk test
Dyspnea Perception
Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea
Quality of Life
Quality of life will be assessed with the "Quality of Life Scale for Children\"
Fear of movement
Fear of movement will be evaluated with Tampa Kinesiophobia Scale
Ability of Motor Imagery
Motor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery
Cognitive Functions
Cognitive functions will be assessed with Trail Making Test and Stroop Test
Healthy Controls
Healthy Peers
Participants will be required to sign an informed consent form before the evaluation.
Assessment Methods:
1. Demographic data (age, height, weight, BMI) will be collected verbally via the assessment form.
2. Pulmonary Function Test will be applied.
3. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
4. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test.
5. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea.
6. Quality of life will be assessed with the "Quality of Life Scale for Children".
7. Fear of movement will be assessed with the Tampa Kinesiophobia Scale.
8. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery.
9. Cognitive functions will be assessed with Trail Making Test and Stroop Test.
Demographic Data
Demographic data (age, height, weight, BMI) will be collected verbally through an assessment form.
Pulmonary Function Test
Pulmonary Function Test will be performed with a spirometer.
Reaction Time
Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
Functional Capacity
Functional capacity will be evaluated with 6 minute walk test
Dyspnea Perception
Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea
Quality of Life
Quality of life will be assessed with the "Quality of Life Scale for Children\"
Fear of movement
Fear of movement will be evaluated with Tampa Kinesiophobia Scale
Ability of Motor Imagery
Motor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery
Cognitive Functions
Cognitive functions will be assessed with Trail Making Test and Stroop Test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Demographic Data
Demographic data (age, height, weight, BMI) will be collected verbally through an assessment form.
Disease History
The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.
Pulmonary Function Test
Pulmonary Function Test will be performed with a spirometer.
Reaction Time
Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
Functional Capacity
Functional capacity will be evaluated with 6 minute walk test
Dyspnea Perception
Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea
Quality of Life
Quality of life will be assessed with the "Quality of Life Scale for Children\"
Fear of movement
Fear of movement will be evaluated with Tampa Kinesiophobia Scale
Ability of Motor Imagery
Motor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery
Cognitive Functions
Cognitive functions will be assessed with Trail Making Test and Stroop Test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being clinically stable
* Not having an exacerbation or infection
* Being between the ages of 7-18
* To be able to read and understand Turkish
Exclusion Criteria
* History of previous lung or liver transplantation
* History of acute exacerbation and/or hospitalization in the last 1 month
* Changes in medical treatment during the study period.
7 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Institutes of Turkey
OTHER_GOV
Atlas University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hilal Denizoğlu Külli
Assoc. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Atlas University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Aysenur Temizel Tombul
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.